GSK, Moderna settle patent dispute over Moderna COVID, RSV shots | Reuters

ReutersView source article

Part of story

GSK and Moderna settle patent dispute over COVID and RSV vaccines

GSK has settled lawsuits accusing Moderna's COVID-19 vaccines Spikevax and mNEXSPIKE and RSV shot mResvia of infringing its patents, resolving a major intellectual property dispute between the two drugmakers.

Nov 6, 20262 sourcesCOVID-19 vaccines Pharmaceutical earnings Intellectual property & trade MRNA vaccine technology Pharmaceutical Industry Pharmaceutical patents

GSK and Moderna settle patent dispute over COVID and RSV vaccines

Other sources for this story

Tech Times

GSK, Moderna settle patent dispute over Moderna COVID, RSV shots | Reuters

Part of story

GSK and Moderna settle patent dispute over COVID and RSV vaccines

Other sources for this story

Moderna Posts $162M Profit, Raises Outlook as Cancer Vaccine Phase 3 Data Published and GSK Patent Dispute Settled

GSK, Moderna settle patent dispute over Moderna COVID, RSV shots | Reuters

Part of story

GSK and Moderna settle patent dispute over COVID and RSV vaccines

Other sources for this story

Moderna Posts $162M Profit, Raises Outlook as Cancer Vaccine Phase 3 Data Published and GSK Patent Dispute Settled